CIM INVESTMENT MANAGEMENT INC - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 162 filers reported holding ESPERION THERAPEUTICS INC NE in Q3 2018. The put-call ratio across all filers is 2.52 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIM INVESTMENT MANAGEMENT INC ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q3 2020$287,000
-26.4%
7,716
+1.5%
0.11%
-30.6%
Q2 2020$390,000
+63.9%
7,604
+17.2%
0.16%
+76.4%
Q3 2019$238,000
-21.2%
6,4860.0%0.09%
-19.8%
Q2 2019$302,000
+5.2%
6,486
-9.2%
0.11%
+0.9%
Q1 2019$287,000
-13.3%
7,144
-0.8%
0.11%
-23.6%
Q4 2018$331,000
+3.4%
7,2050.0%0.14%
+26.3%
Q3 2018$320,000
+13.5%
7,2050.0%0.11%
+17.5%
Q2 2018$282,000
-45.9%
7,2050.0%0.10%
-45.2%
Q1 2018$521,000
+84.1%
7,205
+67.8%
0.18%
+82.5%
Q4 2017$283,000
+28.6%
4,294
-2.0%
0.10%
+21.2%
Q3 2017$220,000
-45.8%
4,381
-50.0%
0.08%
-44.4%
Q2 2017$406,000
+26.9%
8,768
-3.1%
0.14%
+30.9%
Q1 2017$320,000
+42.2%
9,050
-49.6%
0.11%
+34.1%
Q4 2016$225,000
-9.6%
17,9500.0%0.08%
-13.7%
Q3 2016$249,000
+45.6%
17,950
+3.9%
0.10%
+33.8%
Q2 2016$171,000
-35.0%
17,270
+11.1%
0.07%
-38.3%
Q1 2016$263,000
+20.6%
15,550
+482.6%
0.12%
+19.8%
Q2 2015$218,0002,6690.10%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q3 2018
NameSharesValueWeighting ↓
Meditor Group Ltd 4,468,835$22,344,00010.09%
Altium Capital Management LP 2,515,785$12,579,0003.47%
Deep Track Capital, LP 5,641,668$28,208,0001.99%
Paradigm Biocapital Advisors LP 839,257$4,196,0001.20%
SABBY MANAGEMENT, LLC 940,400$4,702,0000.68%
Monaco Asset Management SAM 500,000$2,500,0000.62%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 5,000,000$25,000,0000.52%
CVI Holdings, LLC 1,460,595$7,303,0000.48%
PLATINUM INVESTMENT MANAGEMENT LTD 2,713,176$13,566,0000.38%
Rhenman & Partners Asset Management AB 1,000,000$4,960,0000.33%
View complete list of ESPERION THERAPEUTICS INC NE shareholders